期刊文献+

反相高效液相色谱法测定血浆中多索茶碱的浓度 被引量:13

RP-HPLC method for determination of doxofylline in plasma
暂未订购
导出
摘要 目的 :建立测定人血浆中多索茶碱浓度的反相高效液相色谱法。方法 :采用内标法 ,以 μBondapakC18柱为固定相 ,甲醇 超纯水 (38∶6 2 )为流动相 ,咖啡因为内标 ,检测波长为 2 75nm ,流速为 1.0ml·min-1,柱温 :室温 ;血浆样品无需经过提取 ,直接沉淀蛋白离心后取样进行色谱分析。结果 :样品与内标的峰面积比同样品浓度间线性良好 ,线性范围在 0 .5~16 .0 μg·ml-1,回归方程为 :C =10 .30R - 0 .186 99,r=0 .9992 (n =6 ) ;平均回收率为 99.9% (RSD =0 .15 % ,n =5 )。结论 :该方法简单方便 ,快速 ,准确。 OBJECTIVE To establish a method for determining the concentration of doxofylline in plasma. METHODS Plasma sample was used for the chromatography after protein precipitation and centrifuging on the basis of internal standard method, the μBondapak C 18 column was used. Methanol water (38∶62)(V/V) was used as mobile phase, and caffeine was used as internal standard, with the flow rate of 1.0 ml·min -1 .The detection was carried out at 275 nm. The temperature of column was at room temperatur.RESULTS The separation and determination of the sample and internal standard could be accomplished preferably. The calibration curves were linear in the range of 0.5 ~ 16.0 μg·ml -1 for doxofylline .The average recoveries of doxofylline were 99.9% (RSD= 0.15% , n =5). CONCLUSIONS This method provides a rapid and accurate way to measure the concentration of doxofylline in plasma.
作者 陈吉生 张亮
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2002年第7期406-408,共3页 Chinese Journal of Hospital Pharmacy
关键词 多索茶碱 反相高效液相色谱法 咖啡因 血药浓度 doxofylline RP HPLC caffeine
  • 相关文献

参考文献6

二级参考文献10

  • 1叶丽卡,中国临床药学杂志,1991年,7卷,4期,221页
  • 2 Franzone JS,Cirillo R, Biffignandi P. Doxofylline exerts a prophylactic effect againstbronchocostriction and pleurisy induced by PAF[J]. Eur J Pharmacol, 1989, 165(2)∶269
  • 3 Grossi E, Franzone JS, Biffignandi P,et al. Effect of doxofylline, a novelbronchodilator, and theophylline in reversible COPD patients[J]. J Clin Pharm Ther,1988, 45∶168 [3] Lagana A, Bizzarri M, Marino A,et al. Soild phase extration and highperformance liquid chromatographic determination of doxophylline in plasma[J]. BiomedChromatogr, 1990, 4(5)∶205
  • 4 Bolona E,Lagana A,Terracino D,et al. Oral and intravenous pharmacokineticprofiles of doxofylline in patients with chronic bronchitis[J]. J Int MedRes,1990,18(4)∶282
  • 5 Franzone JS, Cravanzola C, Masera F. Preliminary studies of theabsorption,distribution and excretion of 2-(7'-thephyllinoemethyl)-1,3-dioxolane in rat[J].Farmaco Sci, 1981, 36 (3)∶220
  • 6 Stavaric B. Methylxanthines: toxicity to humans. 1: Theophylline[J]. JChem Toxicol, 1988, 26∶541
  • 7 加藤隆一,钅 兼 哲也编.药物代谢学[M].第3版.东京:东京化学同人,1997.51~61
  • 8 Viillani F, De Maria P, Ronchi E, et al. Oral doxophylline in patients withchronic obstructive pulmonary disease[J]. Int J Clin Pharmacol Ther Toxicol, 1997, 35(3)∶107
  • 9 Grosa G, Franzone JS,Biglino G. Metabolism of doxofylline by rat livermicrosomes[J]. Am Sci Pharmacol & Exp Ther,1986,14 (2)∶33 (收稿:2000-01-14  修回:2000-03-01)
  • 10叶丽卡,李国秀,韩广轩,王尊来,李静梅,阎鸿.慢性阻塞性肺疾病患者服用红霉素对稳态时氨茶碱药代动力学的影响[J].中国临床药理学杂志,1991,7(4):221-224. 被引量:11

共引文献46

同被引文献61

引证文献13

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部